Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Highly Affordable Lab Safety Shield

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
Provides protection for chemists from draughts, splashes, aerosols and spills.

Asynt's Lab Safety Shield has been designed to neatly fit around popular brands of stirrer hotplate to provide protection for chemists from draughts, splashes, aerosols and spills.

Ideal for use where fumehood space is at a premium, the compact and highly affordable Asynt Lab Safety Shield provides additional protection to chemists undertaking applications such as heated parallel reactions in tubes.

The device also beneficially shields reactions from the cooling effect of fumehood ventilation, particularly important when consistent and reproducible heating to parallel experiments is required.

Manufactured from robust 5mm polycarbonate, the Lab Safety Shield is resistant to a wide range of laboratory solvents and is temperature-resistant to 170°C.

Designed with a small footprint (29.5 x 16 x 17cm) to minimize use of valuable fumehood space, the shield maintains access to hotplate controls and gives good all-round visibility of the reaction or process.

Manufactured in the UK, this is the only compact safety shield available for under £100 which fits Asynt, IKA and Heidolph stirrer hotplates.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Asynt DrySyn™ Reaches Out to Aspiring Chemists
Newcastle University’s new Outreach project, which aims to inspire young people to gain interest in chemistry, uses Asynt DrySyn heating blocks.
Thursday, June 24, 2010
A Treasure Trove for the Synthetic Chemist
Asynt’s website offers solutions for synthesis, purification, and evaporation as well as an extensive library of molecular building blocks.
Friday, May 11, 2007
Asynt Announce UK Distribution for the Vapourtec V-10
Versatile V-10 offers extensive flexibility and enables rapid, low temperature evaporation of compounds.
Wednesday, November 30, 2005
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!